The Alexion Takeover Is A Major Expansion For AstraZeneca. Why The Stock Is Down 7%Barrons • 12/14/20
AstraZeneca will acquire Alexion Pharmaceuticals in $39 billion push into rare diseases and immunologyMarket Watch • 12/14/20
Alexion Pharmaceuticals soars 35% after AstraZeneca agrees to $39 billion takeoverBusiness Insider • 12/14/20
Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billionCNN Business • 12/12/20
AstraZeneca is acquiring Alexion Pharmaceuticals in a $39 billion pharmaceutical dealBusiness Insider • 12/12/20
AstraZeneca to Acquire Alexion, Accelerating the Company's Strategic and Financial DevelopmentBusiness Wire • 12/12/20
AstraZeneca will work with the makers of Russia's Sputnik V vaccine to test a combined shot. This could make people more immune, and for a longer period of time, it said.Business Insider • 12/11/20